Jacob E. Gillis

867 citations
11 papers · 574 · 1 hit paper · h-index 8

Impact in

  • Immunology top 10%
    • Immune Cell Function and Interaction
  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Immune Cell Function and Interaction 4
    • IL-33, ST2, and ILC Pathways 2
    • interferon and immune responses 1
    • CRISPR and Genetic Engineering 2

Jacob E. Gillis

10 papers receiving 569 citations

Jacob E. Gillis's Hit Papers

Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance 2023 · 120 citations
1200+1+2Years since publication4080120

Peers

Jacob E. Gillis
Comparison fields: 5 of 66
  • Immunology 224
  • Oncology 257
  • Cancer Research 111
  • Molecular Biology 316
  • Pulmonary and Respiratory Medicine 141
Replace Meidi Gu with:
Meidi Gu United States
Sofia M. Shea United States
Dorine Wouters Netherlands
Matthew Schrage United States
Carmen M. Anadon United States
Tomasz Adamus United States
Li Fu China
Elliot H. Akama‐Garren United States
Tatyana Dvorkin Israel
Vera Petrova Germany
Jacob E. Gillis relative to Meidi Gu United States Meidi Gu's profile →
Citations per field
00.5×
Meidi Gu · 1×
Citations per year

Countries citing papers authored by Jacob E. Gillis

Since Specialization
Citations

This map shows the geographic impact of Jacob E. Gillis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob E. Gillis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob E. Gillis more than expected).

Fields of papers citing papers by Jacob E. Gillis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob E. Gillis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob E. Gillis. The network helps show where Jacob E. Gillis may publish in the future.

Co-authors

The 25 scholars most cited alongside Jacob E. Gillis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jacob E. Gillis Line = papers co-authored together Jacob E. Gillis links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1 2019162
2 2020137
3
Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance
Hit paper breakdown →
2023120
4 201980
5 202425
6 202317
7 201817
8 20238
9 20204
10 20234
11 20250

About Jacob E. Gillis

Jacob E. Gillis is a scholar working on Immunology, Molecular Biology, Oncology, Physiology and Surgery, having authored 11 papers that have together received 574 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (4 papers), Asthma and respiratory diseases (3 papers), IL-33, ST2, and ILC Pathways (2 papers), CAR-T cell therapy research (2 papers), CRISPR and Genetic Engineering (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), interferon and immune responses (1 paper) and Urticaria and Related Conditions (1 paper). The work is most often cited by research in Immunology (224 citations), Oncology (257 citations), Cancer Research (111 citations), Molecular Biology (316 citations) and Pulmonary and Respiratory Medicine (141 citations). Jacob E. Gillis has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Martin W. LaFleur, Arlene H. Sharpe, Thao H. Nguyen, Emily F. Gaudiano, Gordon J. Freeman, W. Nicholas Haining, Kathleen B. Yates, Justin D. Trombley, Debattama R. Sen and Rose Al Abosy. Their work appears in journals such as Nature Immunology, Journal of Diabetes Science and Technology, Journal of Allergy and Clinical Immunology, Nature Communications and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact